. 2019 Mar;25(3).
doi: 10.1038/s41591-019-0376-8.

Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer

Helai P Mohammad 1 Olena Barbash 1 Caretha L Creasy 2 
  • PMID: 30842676
  •     69 citations


Epigenetic dysregulation is a common feature of most cancers, often occurring directly through alteration of epigenetic machinery. Over the last several years, a new generation of drugs directed at epigenetic modulators have entered clinical development, and results from these trials are now being disclosed. Unlike first-generation epigenetic therapies, these new agents are selective, and many are targeted to proteins which are mutated or translocated in cancer. This review will provide a summary of the epigenetic modulatory agents currently in clinical development and discuss the opportunities and challenges in their development. As these drugs advance in the clinic, drug discovery has continued with a focus on both novel and existing epigenetic targets. We will provide an overview of these efforts and the strategies being employed.

Trends and Challenges in Tumor Anti-Angiogenic Therapies.
József Jászai, Mirko H H Schmidt.
Cells, 2019 Sep 22; 8(9). PMID: 31540455    Free PMC article.
Highly Cited. Review.
Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions.
Carolina Colleti, Talita Diniz Melo-Hanchuk, +2 authors, Jörg Kobarg.
World J Biol Chem, 2019 Nov 27; 10(3). PMID: 31768228    Free PMC article.
Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior.
Henry D Reyes, Eric J Devor, +6 authors, Jesus Gonzalez-Bosquet.
Sci Rep, 2019 Dec 01; 9(1). PMID: 31784612    Free PMC article.
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Yun Wang, Jia-Huan Lu, +16 authors, Rui-Hua Xu.
Mol Cancer, 2019 Dec 04; 18(1). PMID: 31791342    Free PMC article.
Is an "Epigenetic Diet" for Migraines Justified? The Case of Folate and DNA Methylation.
Michal Fila, Cezary Chojnacki, Jan Chojnacki, Janusz Blasiak.
Nutrients, 2019 Nov 20; 11(11). PMID: 31739474    Free PMC article.
Histone Methyltransferases as Therapeutic Targets for Kidney Diseases.
Chao Yu, Shougang Zhuang.
Front Pharmacol, 2019 Dec 24; 10. PMID: 31866860    Free PMC article.
Impact of pharmacological agents on mitochondrial function: a growing opportunity?
Megan L Stoker, Emma Newport, +2 authors, Karl J Morten.
Biochem Soc Trans, 2019 Nov 08; 47(6). PMID: 31696924    Free PMC article.
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target.
Panagiotis Karakaidos, John Verigos, Angeliki Magklara.
Cancers (Basel), 2019 Nov 24; 11(12). PMID: 31756917    Free PMC article.
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.
Tosha Williams, David R Borchelt, Paramita Chakrabarty.
Mol Neurodegener, 2020 Feb 02; 15(1). PMID: 32005122    Free PMC article.
The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer.
Yuen Yee Cheng, Emma M Rath, +3 authors, Kenneth Lee.
Lung Cancer (Auckl), 2020 Feb 06; 11. PMID: 32021524    Free PMC article.
miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Liyan Wang, Xiaonan Li, +14 authors, Dongdong Lu.
Mol Ther, 2019 Nov 17; 28(2). PMID: 31732298    Free PMC article.
Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology.
Andre J van Wijnen, Jennifer J Westendorf.
J Orthop Res, 2019 Apr 13; 37(7). PMID: 30977555    Free PMC article.
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy.
Valentina Condelli, Fabiana Crispo, +5 authors, Francesca Maddalena.
Cells, 2019 Jun 06; 8(6). PMID: 31163702    Free PMC article.
Understanding Transcriptional Networks Regulating Initiation of Cutaneous Wound Healing.
Rafik Boudra, Matthew R Ramsey.
Yale J Biol Med, 2020 Apr 01; 93(1). PMID: 32226345    Free PMC article.
Pathogenesis and Clinical Management of Uterine Serous Carcinoma.
Li Zhang, Suet Ying Kwan, +3 authors, Samuel C Mok.
Cancers (Basel), 2020 Mar 19; 12(3). PMID: 32183290    Free PMC article.
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Zhixian Liang, Reilly L Kidwell, Haijing Deng, Qi Xie.
Cancer Biol Med, 2020 Apr 17; 17(1). PMID: 32296573    Free PMC article.
Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21.
Cheng Wu, Ergang Guo, +11 authors, Guoqing Hu.
Mol Ther Oncolytics, 2020 May 10; 17. PMID: 32382655    Free PMC article.
Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients.
Yasmen Ghantous, Aysar Nashef, Imad Abu-Elnaaj.
J Clin Med, 2020 Apr 11; 9(4). PMID: 32272578    Free PMC article.
Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression.
Salina Yuan, Ramakrishnan Natesan, +15 authors, Ben Z Stanger.
Cancer Discov, 2020 Mar 20; 10(6). PMID: 32188706    Free PMC article.
Mechanisms of Multidrug Resistance in Cancer Chemotherapy.
Karol Bukowski, Mateusz Kciuk, Renata Kontek.
Int J Mol Sci, 2020 May 07; 21(9). PMID: 32370233    Free PMC article.
UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Peng Huang, Yuduo Guo, +7 authors, Yongmei Song.
Aging (Albany NY), 2020 Jun 04; 12(11). PMID: 32491994    Free PMC article.
Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Qiliang Peng, Yibin Zhou, +5 authors, Jin Zhu.
Transl Androl Urol, 2020 Jul 18; 9(3). PMID: 32676392    Free PMC article.
circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway.
Peng Zhou, Wei Xie, +5 authors, Zhi-Yuan Li.
Aging (Albany NY), 2020 Jul 10; 12(13). PMID: 32644049    Free PMC article.
Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development.
Yu-Shan Chen, Wei-Shiung Lian, +5 authors, Feng-Sheng Wang.
Int J Mol Sci, 2020 Jul 16; 21(14). PMID: 32664681    Free PMC article.
Computational Prediction of Drug Responses in Cancer Cell Lines From Cancer Omics and Detection of Drug Effectiveness Related Methylation Sites.
Rui Yuan, Shilong Chen, Yongcui Wang.
Front Genet, 2020 Aug 28; 11. PMID: 32849855    Free PMC article.
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.
R Vatapalli, V Sagar, +14 authors, S A Abdulkadir.
Nat Commun, 2020 Aug 21; 11(1). PMID: 32814769    Free PMC article.
Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.
Mélanie Lambert, Meryem Alioui, +3 authors, Marie-Hélène David-Cordonnier.
Cancers (Basel), 2019 Jun 20; 11(6). PMID: 31213012    Free PMC article.
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance.
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, Ann Zeuner.
Front Oncol, 2019 Jul 30; 9. PMID: 31355143    Free PMC article.
Highly Cited. Review.
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia.
Bettina Wingelhofer, Tim C P Somervaille.
Front Oncol, 2019 Sep 26; 9. PMID: 31552175    Free PMC article.
Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.
Eva-Maria Herrlinger, Mirjam Hau, +8 authors, Manfred Jung.
Chembiochem, 2020 Apr 01; 21(16). PMID: 32227662    Free PMC article.
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis.
Nandini Verma, Yaron Vinik, +9 authors, Sima Lev.
Sci Adv, 2020 Sep 17; 6(34). PMID: 32937365    Free PMC article.
Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer.
Yuxin Li, Yao Liu, +5 authors, Wei Cui.
Cell Death Dis, 2020 Sep 17; 11(9). PMID: 32934224    Free PMC article.
The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
Yang Li, Yu-Zheng Ge, +3 authors, Ruipeng Jia.
Front Cell Dev Biol, 2020 Oct 06; 8. PMID: 33015074    Free PMC article.
Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals.
Shamee Bhattacharjee, Roderick H Dashwood.
Antioxidants (Basel), 2020 Sep 18; 9(9). PMID: 32938017    Free PMC article.
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Qian Long, Yijun Hua, +14 authors, Wuguo Deng.
Int J Biol Sci, 2020 Oct 17; 16(15). PMID: 33061812    Free PMC article.
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis.
Florian Wegwitz, Evangelos Prokakis, +5 authors, Steven A Johnsen.
Cell Death Dis, 2020 Oct 19; 11(10). PMID: 33070155    Free PMC article.
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma.
Monica Phimmachanh, Jeremy Z R Han, +2 authors, David R Croucher.
Front Cell Dev Biol, 2020 Oct 30; 8. PMID: 33117806    Free PMC article.
Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer.
Daisuke Obinata, Mitchell G Lawrence, +4 authors, Satoshi Inoue.
Front Oncol, 2020 Nov 03; 10. PMID: 33134178    Free PMC article.
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.
Isha Kapoor, Juraj Bodo, +2 authors, Alexandru Almasan.
Cell Death Dis, 2020 Nov 04; 11(11). PMID: 33139702    Free PMC article.
Comparison of methylation capture sequencing and Infinium MethylationEPIC array in peripheral blood mononuclear cells.
Chang Shu, Xinyu Zhang, Bradley E Aouizerat, Ke Xu.
Epigenetics Chromatin, 2020 Nov 25; 13(1). PMID: 33228774    Free PMC article.
You BETer be aware - learnings from a negative Phase 1 study.
Sophie Postei-Vinoy, Matthias Ocker.
Oncotarget, 2019 May 30; 10(34). PMID: 31139327    Free PMC article.
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise.
Daphné Morel, Daniel Jeffery, +2 authors, Sophie Postel-Vinay.
Nat Rev Clin Oncol, 2019 Oct 02; 17(2). PMID: 31570827
Highly Cited. Review.
Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
Jiajia Wang, Yi Sui, +7 authors, Jie Ma.
Cell Death Dis, 2020 Dec 04; 11(12). PMID: 33268769    Free PMC article.
CaMKII exacerbates heart failure progression by activating class I HDACs.
Manling Zhang, Xue Yang, +7 authors, Ning Feng.
J Mol Cell Cardiol, 2020 Sep 25; 149. PMID: 32971072    Free PMC article.
Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer.
Bo Dong, Zhaoping Qiu, Yadi Wu.
Front Pharmacol, 2020 Dec 22; 11. PMID: 33343366    Free PMC article.
The Role of Epigenomics in Osteoporosis and Osteoporotic Vertebral Fracture.
Kyoung-Tae Kim, Young-Seok Lee, Inbo Han.
Int J Mol Sci, 2020 Dec 17; 21(24). PMID: 33322579    Free PMC article.
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer.
Pasquale Saggese, Assunta Sellitto, +5 authors, Claudio Scafoglio.
Cancers (Basel), 2020 Dec 20; 12(12). PMID: 33339101    Free PMC article.
Identification of lysine isobutyrylation as a new histone modification mark.
Zhesi Zhu, Zhen Han, +12 authors, Y George Zheng.
Nucleic Acids Res, 2020 Dec 15; 49(1). PMID: 33313896    Free PMC article.
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
M Cabezón, R Malinverni, +18 authors, CETLAM group.
Clin Epigenetics, 2021 Jan 16; 13(1). PMID: 33446256    Free PMC article.
Protein arginine methyltransferase 5: a potential cancer therapeutic target.
Yuanyang Yuan, Hong Nie.
Cell Oncol (Dordr), 2021 Jan 21; 44(1). PMID: 33469838
Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3.
Bolin Chen, Chengcheng Dong, Fang Wang, Jiacai Wu.
Onco Targets Ther, 2021 Feb 02; 14. PMID: 33519211    Free PMC article.
BRD4 inhibition sensitizes aggressive non-Hodgkin lymphomas to PI3Kδ inhibitors by suppressing PI3K reactivation and c-MYC expression.
Weiqiong Zuo, Yongxia Zhu, +5 authors, Ningyu Wang.
Am J Cancer Res, 2021 Feb 02; 11(1). PMID: 33520370    Free PMC article.
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.
Darleny Y Lizardo, Chaoyuan Kuang, +3 authors, Lin Zhang.
Biochim Biophys Acta Rev Cancer, 2020 Oct 10; 1874(2). PMID: 33035640    Free PMC article.
Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma.
Xiaohua Liu, Yu Zhang, +7 authors, Ao Zhang.
Acta Pharm Sin B, 2021 Mar 02; 11(2). PMID: 33643826    Free PMC article.
Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer.
Tzuriel Sapir, David Shifteh, +2 authors, Radhashree Maitra.
Mol Cancer Res, 2020 Dec 09; 19(3). PMID: 33288733    Free PMC article.
Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
Tongyan Liu, Chencheng Han, +8 authors, Rong Yin.
Cell Mol Life Sci, 2020 Nov 11; 78(5). PMID: 33170304    Free PMC article.
Multiple Endocrine Neoplasia Type 1: Latest Insights.
Maria Luisa Brandi, Sunita K Agarwal, +3 authors, Rajesh V Thakker.
Endocr Rev, 2020 Nov 30; 42(2). PMID: 33249439    Free PMC article.
Epigenetic mechanisms in breast cancer therapy and resistance.
Liliana Garcia-Martinez, Yusheng Zhang, +2 authors, Lluis Morey.
Nat Commun, 2021 Mar 21; 12(1). PMID: 33741974    Free PMC article.
The SWI/SNF complex in cancer - biology, biomarkers and therapy.
Priya Mittal, Charles W M Roberts.
Nat Rev Clin Oncol, 2020 Apr 19; 17(7). PMID: 32303701
Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Mingxing Xu, Hao Liang, +4 authors, Nan Lin.
Aging (Albany NY), 2021 Feb 04; 13(4). PMID: 33535183    Free PMC article.
A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer.
Mengping Long, Wei Hou, Yiqiang Liu, Taobo Hu.
Curr Oncol, 2021 Feb 23; 28(1). PMID: 33617509    Free PMC article.
Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Jiachen Wen, M Kyle Hadden.
Eur J Med Chem, 2021 Feb 27; 215. PMID: 33636537    Free PMC article.
Role of RNA modifications in cancer.
Isaia Barbieri, Tony Kouzarides.
Nat Rev Cancer, 2020 Apr 18; 20(6). PMID: 32300195
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system.
Qiliang Peng, Yi Shen, +4 authors, Jin Zhu.
Aging (Albany NY), 2021 Mar 10; 13(5). PMID: 33686949    Free PMC article.
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs.
Patrizia D'Aquila, Domenica Ronchetti, +9 authors, Nicola Amodio.
J Clin Med, 2021 Apr 04; 10(6). PMID: 33801014    Free PMC article.
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.
Oriol de Barrios, Maribel Parra.
Int J Mol Sci, 2021 Apr 04; 22(6). PMID: 33803872    Free PMC article.
Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach.
Mohammad Reza Kalhori, Hamid Khodayari, +4 authors, Anupam Bishayee.
Cancers (Basel), 2021 Apr 04; 13(6). PMID: 33805687    Free PMC article.
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends.
Kunal Nepali, Jing-Ping Liou.
J Biomed Sci, 2021 Apr 13; 28(1). PMID: 33840388    Free PMC article.
Advances in epigenetic therapeutics with focus on solid tumors.
Ning Jin, Tiffany L George, +6 authors, Kai He.
Clin Epigenetics, 2021 Apr 22; 13(1). PMID: 33879235    Free PMC article.